Purpose To systematically review the literature evaluating clinical utility of imaging metrics
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …

Background: Although many works have supported the utility of PET radiomics, several
authors have raised concerns over the robustness and replicability of the results. This study …

Objectives To perform a systematic review regarding the developments in the field of
radiomics in lymphoma. To evaluate the quality of included articles by the Quality …

Malignant lymphomas are a family of heterogenous disorders caused by clonal proliferation
of lymphocytes. 18F-FDG-PET has proven to provide essential information for accurate …

Radiomic analysis provides information on the underlying tumour heterogeneity in
lymphoma, reflecting the real-time evolution of malignancy. 2-Deoxy-2-[18F] fluoro-D …

Purpose This study aimed to develop a novel analytic approach based on 2-deoxy-2-[18 F]
fluoro-D-glucose positron emission tomography/computed tomography ([18 F] FDG PET/CT) …

Purpose Tumor microenvironment immune types (TMITs) are closely related to the efficacy
of immunotherapy. We aimed to assess the predictive ability of 18F-fluorodeoxyglucose …

18F-FDG PET/CT is used clinically for the detection of extramedullary lesions in patients with
relapsed acute leukemia (AL). However, the visual analysis of 18F-FDG diffuse bone …

Objectives To identify an 18 F-fluorodeoxyglucose (18 F-FDG) positron emission
tomography (PET) radiomics-based model for predicting progression-free survival (PFS) and …

Simple Summary Lymphoma is a type of cancer that affects the immune system and can be
difficult to diagnose and treat effectively, especially in the early stages. Current imaging …